Northwest Biotherapeutics (NWBO) Cash from Financing Activities (2010 - 2026)
Northwest Biotherapeutics (NWBO) reported Cash from Financing Activities of $7.37 million for Q2 2026, down 40.8% from $12.45 million a year earlier and down 19.9% from the prior quarter.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Northwest Biotherapeutics' Cash from Financing Activities came in at $41.73 million, down 19.4% year-over-year; for FY2025, it came in at $49.33 million, down 13.1% from FY2024.
- Cash from Financing Activities has a five-year compound annual growth rate of -1.3% (FY2020 to FY2025).
- By year, Cash from Financing Activities came in at $56.79 million in FY2024 (+7.6%), $52.76 million in FY2023 (+25.7%), $41.97 million in FY2022 (-12.8%) and $48.13 million in FY2021 (-8.7%).
- The Q2 2026 figure ranks as the lowest quarterly Cash from Financing Activities since Q1 2022.
- Year over year, Cash from Financing Activities has now declined in each of the last six quarters, with an average decline of 16.2% over the last eight quarters.
- The high point for year-over-year Cash from Financing Activities in five years was Q1 2023 (growth of 221.0%); the low point was Q1 2022 (a decline of 63.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $9.21 million (Q1 2026), $13.59 million (Q4 2025) and $11.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Northwest Biotherapeutics | 250.40 Mn | 240.41 Mn | - | 7.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.37 Mn |
| Mar 31, 2026 | 9.21 Mn |
| Dec 31, 2025 | 13.59 Mn |
| Sep 30, 2025 | 11.56 Mn |
| Jun 30, 2025 | 12.45 Mn |
| Mar 31, 2025 | 11.73 Mn |
| Dec 31, 2024 | 15.94 Mn |
| Sep 30, 2024 | 11.62 Mn |
| Jun 30, 2024 | 17.14 Mn |
| Mar 31, 2024 | 12.09 Mn |
| Dec 31, 2023 | 14.42 Mn |
| Sep 30, 2023 | 17.12 Mn |
| Jun 30, 2023 | 8.64 Mn |
| Mar 31, 2023 | 12.58 Mn |
| Dec 31, 2022 | 11.35 Mn |
| Sep 30, 2022 | 16.29 Mn |
| Jun 30, 2022 | 10.41 Mn |
| Mar 31, 2022 | 3.92 Mn |
| Dec 31, 2021 | 23.67 Mn |
| Sep 30, 2021 | 8.92 Mn |
API Access
Northwest Biotherapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();